INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
23/01/2026
Voltar para busca
Dado oficial do USPTO
KISTOSYN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
24/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
03/01/2017
Data de registro
06/11/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/05/2025
Última transação
24/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
HU
Examinador
DELANEY, ZHALEH SYBIL
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
C. K. (pessoa física)
Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
Representantes
Engel és Eszes Ügyvédi Iroda
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Aldehydes for pharmaceutical purposes; alginate dietary supplements; aloe vera preparations for pharmaceutical purposes; amino acids for medical purposes; anti-oxidant food supplements; antioxidant enriched coffee for medical purposes; antibiotics; antibiotics for human use; mineral food supplements; food supplements in the nature of anti-oxidants in pill form; mineral waters for medical purposes; asthmatic tea; bacteriological preparations for medical and veterinary use; cultures of microorganisms and biological tissue cultures all for medical and veterinary use; bacterial poisons; bacterial preparations for medical and veterinary use; medicinal diaper rash ointments; medicinal ointments for treating dermatological conditions; balms for medical purposes; gurjun balsam preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases for both medical and veterinary purposes; medicated skin care lotions; skin care creams for medical use; wheat germ dietary supplements; melissa water for pharmaceutical purposes; gallic acid for pharmaceutical purposes; stick liquorice for pharmaceutical purposes; medicinal herbs in the nature of fennel; dietary fiber to aid digestion; dietary fiber for treating constipation; yeast for pharmaceutical purposes; yeast dietary supplements; yeast extracts for pharmaceutical purposes; pharmaceutical preparationselixirs for the treatment of viral and bacterial infections; enzymes for medical purposes; enzyme preparations for medical purposes; cardiotonics; enzyme dietary supplements; expectorants composed of eucalyptol; eucalyptus for pharmaceutical purposes; sterilising preparations; disinfectants; disinfectants and antiseptics; germicides; disinfectants other than disinfectant soap; disinfectants for medical instruments; fumigants; glucose for medical purposes; dietetic by-products of the processing of cereals adapted for medical purposes; glucose dietary supplements; glucose preparations for medical purposes; fungicides; fungicides for medical use; biological fungicides; fungal extracts sold as a component ingredient of nutritional supplements and vitamins; medicinal tea; medicinal drinks; medicinal herbs; medicated candy; extracts of medicinal herbs; herbal teas for medicinal purposes; nutritionally fortified herbal beverages for medical purposes; medicinal herbal extracts for medical purposes; pharmaceutical preparations for the treatment of respiratory diseases; medicated lozenges; sugar-coated medicated lozenges; medicated food supplements; herbal extracts for medical purposes; plant extracts for medical purposes; herbal pills for the treatment of diabetes; natural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; medicinal herbal preparations; rhubarb roots for pharmaceutical purposes; aloe vera preparations for pharmaceutical purposes; medicinal herbs for smoking cessation; herbal teas for medicinal purposes; urinary tract disinfectants; anti-uric preparations; vaginal washes for medical purposes; douching preparations for medical purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue featuring irish moss; iodine; iodine for pharmaceutical purposes; potassiumsodium and silver iodides for pharmaceutical purposes; camphor oil for medical purposes; camphor for medical purposes; candy for medical purposes; dill oil for medical purposes; capsules sold empty for pharmaceuticals; parasiticides; disposable wipes impregnated with pharmaceutical lotions; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use on plastic and metal surface objects; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in householdsvehicleshotels and hospitals; pre-moistened medicated wipes; ointments for pharmaceutical purposes; sulfur sticks as disinfectants; flowers of sulfur for pharmaceutical purposes; angostura bark for medical purposes; mangrove bark for pharmaceutical purposes; quebracho bark for medical use; condurango bark for medical purposes; croton bark for medical purposes; collodion for pharmaceutical purposes; extracts of hops for pharmaceutical purposes; air purifying preparations; disinfectant washes for sanitary purposes; sanitary sterilizing preparations in the nature of washes; royal jelly for pharmaceutical purposes; royal jelly dietary supplements; mint for pharmaceutical purposes; menthol for pharmaceutical purposes; mentholated ointment for medical use; mustard poultices for pharmaceutical purposes; medicated body powder composed of mustard; mustard oil for medical purposes; medicinal herb preparations composed of mustard; medicinal roots; myrobalan barks for pharmaceutical purposes; prescription and non-prescription medicinescapsules and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal oils; medicated lozenges for the treatment of respiratory diseases; cough lozenges for medical use; pollen dietary supplements; propolis for pharmaceutical purposes; propolis dietary supplements; chewing gum for medical purposes; medicated bath salts; medicated mouthwash; mouthwashes for medical purposes; gargles for medical purposes; medicated anti-cavity mouth spray; medicated dental rinse; antiseptic mouthwashes; medicated mouthwashesantimicrobial mouthwashes; medicated serums for the treatment of the mouth and throat; syrups for pharmaceutical purposes for the treatment of the mouth for disinfection and for the treatment of respiratory diseases; tinctures of iodine for medical purposes; detergents for medical purposes; vaccines; vitamin tablets; vitamin preparations; vitamin supplements; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; mixed vitamin preparations; gelatin capsules sold empty for pharmaceuticals; fumigation preparations for medical purposes; gurjun balsam for medical purposes; bronchodilating preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
C71T
CANCELLED SECTION 71
23/05/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/02/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/04/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/02/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
09/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2018
PUBO
PUBLISHED FOR OPPOSITION
21/08/2018
GPNX
NOTIFICATION PROCESSED BY IB
17/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/08/2018
NPUB
NOTICE OF PUBLICATION
01/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/07/2018
CNEA
EXAMINERS AMENDMENT MAILED
16/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
14/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/07/2018
CNFR
FINAL REFUSAL MAILED
12/01/2018
CNFR
FINAL REFUSAL WRITTEN
11/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/12/2017
ALIE
ASSIGNED TO LIE
21/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/12/2017
RFNT
REFUSAL PROCESSED BY IB
04/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/07/2017
RFRR
REFUSAL PROCESSED BY MPU
20/07/2017
MAFR
APPLICATION FILING RECEIPT MAILED
18/07/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/07/2017
CNRT
NON-FINAL ACTION WRITTEN
13/07/2017
DOCK
ASSIGNED TO EXAMINER
12/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/07/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/07/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KISTOSYN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.